IRIS
PLANTONE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.038
EU - Europa 3.830
AS - Asia 3.277
SA - Sud America 907
AF - Africa 314
OC - Oceania 8
Totale 12.374
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.929
SG - Singapore 1.143
RU - Federazione Russa 1.051
IT - Italia 791
CN - Cina 790
BR - Brasile 745
IE - Irlanda 659
VN - Vietnam 400
FR - Francia 318
HK - Hong Kong 305
SE - Svezia 289
GB - Regno Unito 199
ZA - Sudafrica 150
BD - Bangladesh 139
KR - Corea 134
DE - Germania 126
ES - Italia 105
FI - Finlandia 97
IN - India 90
NG - Nigeria 84
AR - Argentina 60
CA - Canada 50
NL - Olanda 47
IQ - Iraq 45
ID - Indonesia 34
EC - Ecuador 31
MX - Messico 29
KE - Kenya 28
AT - Austria 26
SA - Arabia Saudita 26
TR - Turchia 26
JP - Giappone 24
PK - Pakistan 20
BE - Belgio 17
CL - Cile 16
CO - Colombia 14
CZ - Repubblica Ceca 14
UA - Ucraina 13
CH - Svizzera 12
PL - Polonia 12
PY - Paraguay 12
VE - Venezuela 11
LT - Lituania 10
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IR - Iran 8
MA - Marocco 8
TN - Tunisia 8
UZ - Uzbekistan 8
AL - Albania 7
AU - Australia 7
DZ - Algeria 7
JO - Giordania 7
PE - Perù 7
AZ - Azerbaigian 6
IL - Israele 6
KZ - Kazakistan 6
MY - Malesia 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
HU - Ungheria 5
NP - Nepal 5
RO - Romania 5
UY - Uruguay 5
AM - Armenia 4
CI - Costa d'Avorio 4
NI - Nicaragua 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
QA - Qatar 3
BG - Bulgaria 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TG - Togo 2
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
Totale 12.353
Salva come PNG Salva come JPEG
Città #
Dallas 1.021
Dublin 643
Singapore 531
Chandler 378
Santa Clara 339
Hong Kong 293
Moscow 285
Hefei 219
Ashburn 165
Beijing 165
Princeton 165
Milan 155
Fairfield 143
San Jose 141
Ho Chi Minh City 140
Johannesburg 140
Seoul 134
Council Bluffs 112
Hanoi 105
Lauterbourg 105
Los Angeles 99
Southend 88
Málaga 87
Wilmington 86
Abuja 81
New York 74
São Paulo 65
Helsinki 59
Siena 51
Redondo Beach 46
Buffalo 44
Rome 40
Houston 38
Seattle 38
Woodbridge 35
San Diego 33
Ann Arbor 29
Bengaluru 29
Florence 29
Frankfurt am Main 29
Nuremberg 29
Lappeenranta 28
The Dalles 28
Cambridge 26
London 25
Orem 22
Munich 21
Baghdad 20
Lucca 20
Belo Horizonte 19
Chicago 18
Pisa 18
Riyadh 18
Naples 17
Chennai 16
Haiphong 16
Toronto 16
Brussels 14
Brno 13
Messina 13
Quito 13
Rio de Janeiro 13
Shanghai 13
Tokyo 13
Brooklyn 12
Columbus 12
Livorno 12
Nairobi 12
Phoenix 12
Atlanta 11
Biên Hòa 11
Bologna 11
Campinas 11
City of London 11
Da Nang 11
Goiânia 11
Guangzhou 11
Porto Alegre 11
San Francisco 11
Vienna 10
Basingstoke 9
Curitiba 9
Bari 8
Brasília 8
Istanbul 8
Jakarta 8
Turku 8
Warsaw 8
Amman 7
Aracaju 7
Carlentini 7
Fortaleza 7
Genoa 7
Jacksonville 7
Montreal 7
Norwalk 7
Salvador 7
Sarzana 7
Stockholm 7
Tashkent 7
Totale 7.238
Salva come PNG Salva come JPEG
Nome #
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 476
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 188
Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases 180
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 173
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 171
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 160
B Lymphocytes in Alzheimer's Disease-A Comprehensive Review 159
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 153
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 152
Neurological diseases associated with autoantibodies targeting the voltage-gated potassium channel complex: immunobiology and clinical characteristics 149
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study 148
Does Lumbar Puncture Still Have Clinical Value for Patients with Amyotrophic Lateral Sclerosis? 143
Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers 142
Acute Necrotizing Encephalopathy during Novel Influenza A (H1N1) Virus Infection 140
A neurometabolic profile of SPMS: the relationship between brain metabolites and clinical disability 139
Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis 138
Peripherin, a new promising biomarker in neurological disorders 133
Acute refractory intestinal pseudo-obstruction in MELAS : Efficacy of prucalopride 133
Anorexia Heralding the Onset of Neuromyelitis Optica 133
Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators 131
A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 131
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 129
Amiloride, Fluoxetine or Riluzole to Reduce Brain Volume Loss in Secondary Progressive Multiple Sclerosis: The MS-SMART Four-Arm RCT 128
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis 128
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 128
Vitamin D in neurological diseases 127
A Neurometabolic Profile of Secondary Progressive Multiple Sclerosis: The Relationship between Brain Metabolites and Clinical Disability 126
Serum growth differentiation factor-15, glial fibrillary acidic protein, and neurofilament light chain: Their link and role in Creutzfeldt-Jakob disease 125
A case of hemorrhagic Wernicke's encephalopathy following gastric surgery 123
Atlantoaxial subluxation in rheumatoid arthritis 123
Antiphospholipid antibodies: a possible biomarker of disease activity in multiple sclerosis and neuromyelitis optica spectrum disorders 121
A longitudinal study of spinal cord atrophy in progressive multiple sclerosis 116
Association between Anemia and Multiple Sclerosis 115
Investigating interleukin-8 in Alzheimer's disease: a comprehensive review 112
Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients 112
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 110
CD4(+)T-bet(+), CD4(+)pSTAT3(+) and CD8(+)T-bet(+) T cells accumulate in peripheral blood during NZB treatment 109
A new national survey of centers for cognitive disorders and dementias in Italy 109
Brainstem and spinal cord involvement in a paraneoplastic syndrome associated with anti-Yo antibody and breast cancer 105
Brain perfusion by arterial spin labeling MRI in multiple sclerosis 103
The Role of TNF-α in Alzheimer’s Disease: A Narrative Review 102
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 102
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 101
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial 101
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review 99
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments 98
Riboflavin in Neurological Diseases: A Narrative Review 98
Insights into the role of cerebrospinal fluid cytokines in Alzheimer's disease: A commentary on recent findings 96
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumab 96
NAA is a Marker of Disability in Secondary-Progressive MS: A Proton MR Spectroscopic Imaging Study 96
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 95
CD8+effector and memory T cell subsets in relapsing-onset Multiple Sclerosis 95
Retinal nerve fibre layer thickness in the temporal quadrant predicts clinical disability and cervical cord cross sectional area in secondary progressive multiple sclerosis 95
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis 94
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients 94
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 94
HIV and lower risk of multiple sclerosis: role of adaptive immune response 94
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview 93
CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients 93
Circulating CD8(+)CD56(-)perforin(+) T cells are increased in multiple sclerosis patients 93
Neurofilament heavy chain in secondary progressive multiple sclerosis 92
HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence 92
Natural killer lymphocytes in HIV and multiple sclerosis 92
Is There a Role of Vitamin D in Alzheimer's disease? 92
Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report 90
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 89
Tumefactive Demyelinating Lesions and Pregnancy 89
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis 89
Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis 89
Brain reserve and physical disability in secondary progressive multiple sclerosis 88
Increased CD4(+)CD25(+)Foxp3(+) T cells in peripheral blood of celiac disease patients: Correlation with dietary treatment 88
Teaching NeuroImages: A case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody 88
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis 87
PPIs as possible risk factor for copper deficiency myelopathy 87
Paroxysmal ataxia and dysarthria in multiple sclerosis 87
Initial cross-sectional MR spectroscopy analysis of a cohort of secondary progressive MS patients enrolled in the MS-SMART trial 87
Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS 87
Optical coherence tomography in secondary progressive multiple sclerosis: a baseline data report from the MS-SMART trial 87
Psychological General Well-being, Cognitive Failure, and Inflammation Biomarkers Among Workers 4 Months After a Mild/Asymptomatic SARS-CoV-2 Infection 86
Midbrain Panda Sign in a Patient with Wilsons Disease 86
Type 1 immune response in progressive multiple sclerosis 86
Osteoma of the Internal Auditory Canal 86
Teaching NeuroImages: Basal ganglia involvement in facio-brachial dystonic seizures associated with LGI1 antibodies 86
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial 85
Inflammatory profile in mitochondrial diseases: a cohort study 84
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 84
Concurrence of multiple sclerosis and brain tumors 84
Systematic assessment and characterization of chronic pain in multiple sclerosis patients: preliminary results 84
MTR-derived pial and subpial abnormalities in the spinal cord of RRMS patients: a two-year follow-up study 84
Reply [a: Influenza A (H1N1) in cerebrospinal fluid sample and encephalopathy by Sandoval-Gutiérrez JM, Arcos M, Alva L, Volkow P, T Ferrari T, Quiñones F, Vázquez-Pérez J, Ormsby JE, Hanssen F, Reséndiz A, Alcántara P, Pérez Padilla R, Bautista E] 83
Spinal cord area is a stronger predictor of physical disability than brain volume in secondary progressive Multiple Sclerosis 83
T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity 82
Dimethyl fumarate may still have a role in progressive multiple sclerosis 80
The detection of neural autoantibodies in patients with antiepileptic- drug-resistant epilepsy predicts response to immunotherapy 80
Neuroradiological characterization of multiple sclerosis patients with chronic pain 80
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations 79
Secondary Progressive Multiple Sclerosis: Definition and Measurement 79
Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis 79
Neuroimaging Correlates of Longitudinally Extensive Transverse Myelitis in AQP4-IgG Positive and AQP4-IgG Negative Patients 79
Investigating the impact of different dichotomous definitions for cognitive impairment on functional connectivity in secondary progressive MS 78
Totale 11.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 290 214 59 22 7 90 43 29 76 302
2022/20231.358 133 129 174 170 81 249 45 82 152 94 24 25
2023/2024840 44 28 35 21 18 223 288 14 5 18 20 126
2024/20252.629 88 148 170 133 279 156 53 143 211 173 256 819
2025/20266.827 488 948 1.053 852 1.021 209 735 304 298 369 368 182
Totale 12.786